BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27916639)

  • 1. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
    Williams G; Ferenczy GG; Ulander J; Keserű GM
    Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based drug discovery and its application to challenging drug targets.
    Price AJ; Howard S; Cons BD
    Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying thermodynamic profiling in lead finding and optimization.
    Klebe G
    Nat Rev Drug Discov; 2015 Feb; 14(2):95-110. PubMed ID: 25614222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Native Mass Spectrometry in Fragment-Based Drug Discovery.
    Pedro L; Quinn RJ
    Molecules; 2016 Jul; 21(8):. PubMed ID: 27483215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
    Hoffer L; Renaud JP; Horvath D
    J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic profiling for fragment-based lead discovery and optimization.
    Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2020 Jan; 15(1):117-129. PubMed ID: 31741402
    [No Abstract]   [Full Text] [Related]  

  • 7. Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design.
    Faller CE; Raman EP; MacKerell AD; Guvench O
    Methods Mol Biol; 2015; 1289():75-87. PubMed ID: 25709034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
    Barelier S; Krimm I
    Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
    Ferreira LG; Andricopulo AD
    Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of binding thermodynamics on medicinal chemistry optimizations.
    Ferenczy GG; Keserű GM
    Future Med Chem; 2015; 7(10):1285-303. PubMed ID: 26144265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational approach to de novo discovery of fragment binding for novel protein states.
    Konteatis ZD; Klon AE; Zou J; Meshkat S
    Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General Theory of Fragment Linking in Molecular Design: Why Fragment Linking Rarely Succeeds and How to Improve Outcomes.
    Yu HS; Modugula K; Ichihara O; Kramschuster K; Keng S; Abel R; Wang L
    J Chem Theory Comput; 2021 Jan; 17(1):450-462. PubMed ID: 33372778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamics of fragment binding.
    Ferenczy GG; Keserű GM
    J Chem Inf Model; 2012 Apr; 52(4):1039-45. PubMed ID: 22458364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragments: where are we now?
    Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
    Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics.
    Lu H; Iuliano JN; Tonge PJ
    Curr Opin Chem Biol; 2018 Jun; 44():101-109. PubMed ID: 29986213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
    Roughley SD; Hubbard RE
    J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
    [No Abstract]   [Full Text] [Related]  

  • 19. New approaches for computing ligand-receptor binding kinetics.
    Bruce NJ; Ganotra GK; Kokh DB; Sadiq SK; Wade RC
    Curr Opin Struct Biol; 2018 Apr; 49():1-10. PubMed ID: 29132080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACFIS: a web server for fragment-based drug discovery.
    Hao GF; Jiang W; Ye YN; Wu FX; Zhu XL; Guo FB; Yang GF
    Nucleic Acids Res; 2016 Jul; 44(W1):W550-6. PubMed ID: 27150808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.